| human | Q5 |
| P6178 | Dimensions author ID | 0677433706.45 |
| P227 | GND ID | 125036549X |
| P213 | ISNI | 0000000044287681 |
| P496 | ORCID iD | 0000-0001-7292-1114 |
| P214 | VIAF cluster ID | 56338448 |
| P69 | educated at | University of Sydney | Q487556 |
| University of New South Wales | Q734764 | ||
| P108 | employer | Royal North Shore Hospital | Q7374599 |
| P735 | given name | Aaron | Q905085 |
| Aaron | Q905085 | ||
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| Q92092134 | Adapting to a pandemic - conducting oncology trials during the SARS-CoV-2 pandemic |
| Q38866405 | An ethnopharmacological approach to the preliminary screening of native Australian herbal medicines for anticancer activity. |
| Q89861115 | Brain Metastases in Lung Cancers with Emerging Targetable Fusion Drivers |
| Q54295588 | Candida glabrata vertebral osteomyelitis in an immunosuppressed patient. |
| Q58581856 | Characteristics and outcomes of oncology unit patients requiring admission to an Australian intensive care unit |
| Q93017433 | Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade |
| Q48131448 | Cisplatin-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH) with life-threatening hyponatraemia. |
| Q86515398 | Complementary and alternative medicine in diabetes (CALMIND)--a prospective study |
| Q48270057 | Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancer. |
| Q91100501 | FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma |
| Q39911943 | High-throughput screening platform for anticancer therapeutic drug cytotoxicity. |
| Q39247421 | Immune Checkpoint Inhibitors for Brain Metastases |
| Q38743793 | Immune Checkpoint Inhibitors in Gliomas. |
| Q96030088 | Management of glioblastoma: State of the art and future directions |
| Q92379145 | Molecular and clonal evolution in recurrent metastatic gliosarcoma |
| Q37866180 | Molecular pathways for cancer chemoprevention by dietary phytochemicals. |
| Q39578342 | Native Australian fruit polyphenols inhibit cell viability and induce apoptosis in human cancer cell lines. |
| Q59136693 | New drug developments in metastatic gastric cancer |
| Q39482727 | Potential Antioxidant, Antiinflammatory, and Proapoptotic Anticancer Activities of Kakadu Plum and Illawarra Plum Polyphenolic Fractions |
| Q104749810 | Salting the soil: Targeting the microenvironment of brain metastases |
| Q38235891 | Subacute delayed ascending myelopathy: not just a post-traumatic disorder. |
| Q92988350 | Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC) |
| Q98574191 | The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts |
| Q37784093 | Towards the discovery of novel phytochemicals for disease prevention from native Australian plants: an ethnobotanical approach. |
Search more.